{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T08:05:35Z","timestamp":1774771535599,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["20100"],"award-info":[{"award-number":["20100"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006692","name":"Universit\u00e0 degli Studi di Torino","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006692","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>In non-papillary follicular cell-derived thyroid carcinomas, prognostic factors are scarce. Intratumoral fibrosis was identified as an adverse factor in papillary and medullary carcinomas, but it has not been investigated in other subtypes. We aimed at exploring the presence of intratumoral fibrosclerosis in a cohort of 132 non-papillary follicular cell-derived thyroid carcinomas (53 follicular and 31 oncocytic carcinomas, including 10 high grade differentiated thyroid carcinomas and 48 poorly differentiated carcinomas) and correlating its presence and extent with clinical and pathological features and survival. For each case, all available hematoxylin and eosin slides were reviewed, and the presence of fibrosclerosis was assessed as the percentage of tumor area and semi-quantitatively scored as absent, mild (\u2264\u200910%) or extensive (&gt;\u200910%). In addition, digital image analysis was applied in 65 cases. Scoring of intratumoral fibrosis showed a strong agreement between two observers and between observers and digital image quantification. The presence and extent of intratumoral fibrosis were significantly associated with poorly differentiated carcinoma histology, large tumor size, extent of vascular invasion, presence of necrosis, high mitotic index, positive nodal status, and aggressive clinical outcome, and with a shorter disease-free and disease-specific survival, the former also in follicular and oncocytic carcinomas analyzed separately. These data support the potential use of fibrosis in the clinical practice since it is both easily assessable and significantly associated with the presence of parameters of aggressiveness. In addition, fibrosis is correlated with decreased survival rate independently from the tumor histotypes, suggesting its potential role as novel prognostic factor in non-papillary follicular cell-derived thyroid carcinomas.<\/jats:p>","DOI":"10.1007\/s00428-025-04028-2","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T13:30:39Z","timestamp":1737639039000},"page":"701-711","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prognostic impact of fibrosclerotic changes in non-papillary, non-anaplastic, follicular cell-derived thyroid carcinomas"],"prefix":"10.1007","volume":"487","author":[{"given":"Giulia","family":"Orlando","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Capella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Vocino Trucco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Vissio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasna","family":"Metovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Maletta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0719-105X","authenticated-orcid":false,"given":"Marco","family":"Volante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Papotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,23]]},"reference":[{"key":"4028_CR1","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s12020-023-03466-9","volume":"82","author":"T Zhang","year":"2023","unstructured":"Zhang T, He L, Wang Z, Dong W, Sun W, Zhang P, Zhang H (2023) Risk factors for death of follicular thyroid carcinoma: a systematic review and meta-analysis. Endocrine 82:457\u2013466. https:\/\/doi.org\/10.1007\/s12020-023-03466-9","journal-title":"Endocrine"},{"key":"4028_CR2","doi-asserted-by":"publisher","unstructured":"Stegenga MT, van Velsen EFS, Oudijk L, Verburg FA, van Ginhoven TM, Peeters RP, Medici M, Visser WE, van Kemenade FJ (2024) Clinical and histopathological risk factors for radioactive iodine refractory follicular and oncocytic thyroid carcinoma. J Clin Endocrinol Metab. Feb 13:dgae084. https:\/\/doi.org\/10.1210\/clinem\/dgae084","DOI":"10.1210\/clinem\/dgae084"},{"key":"4028_CR3","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s00268-022-06696-6","volume":"47","author":"D Leong","year":"2023","unstructured":"Leong D, Gill AJ, Turchini J, Waller M, Clifton-Bligh R, Glover A, Sywak M, Sidhu S (2023) The prognostic impact of extent of vascular invasion in follicular thyroid carcinoma. World J Surg 47:412\u2013420. https:\/\/doi.org\/10.1007\/s00268-022-06696-6","journal-title":"World J Surg"},{"key":"4028_CR4","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1507\/endocrj.EJ22-0077","volume":"69","author":"Y Ito","year":"2022","unstructured":"Ito Y, Hirokawa M, Masuoka H, Higashiyama T, Kihara M, Onoda N, Miya A, Miyauchi A (2022) Prognostic factors for follicular thyroid carcinoma: the importance of vascular invasion. Endocr J 69:1149\u20131156. https:\/\/doi.org\/10.1507\/endocrj.EJ22-0077","journal-title":"Endocr J"},{"key":"4028_CR5","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1210\/clinem\/dgad689","volume":"109","author":"H Yamazaki","year":"2023","unstructured":"Yamazaki H, Sugino K, Katoh R, Matsuzu K, Kitagawa W, Nagahama M, Rino Y, Saito A, Ito K (2023) Role of the degree of vascular invasion in predicting prognosis of follicular thyroid carcinoma. J Clin Endocrinol Metab 109:1291\u20131300. https:\/\/doi.org\/10.1210\/clinem\/dgad689","journal-title":"J Clin Endocrinol Metab"},{"key":"4028_CR6","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.3803\/EnM.2021.1151","volume":"36","author":"M Jin","year":"2021","unstructured":"Jin M, Kim ES, Kim BH, Kim HK, Kang YE, Jeon MJ, Kim TY, Kang HC, Kim WB, Shong YK, Kim M, Kim WG (2021) Clinicopathological characteristics and disease-free survival in patients with H\u00fcrthle cell carcinoma: a multicenter cohort study in South Korea. Endocrinol Metab (Seoul) 36:1078\u20131085. https:\/\/doi.org\/10.3803\/EnM.2021.1151","journal-title":"Endocrinol Metab (Seoul)"},{"key":"4028_CR7","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1089\/thy.2021.0424","volume":"32","author":"D Matsuura","year":"2022","unstructured":"Matsuura D, Yuan A, Wang L, Ranganath R, Adilbay D, Harries V, Patel S, Tuttle M, Xu B, Ghossein R, Ganly I (2022) Follicular and Hurthle cell carcinoma: comparison of clinicopathological features and clinical outcomes. Thyroid 32:245\u2013254. https:\/\/doi.org\/10.1089\/thy.2021.0424","journal-title":"Thyroid"},{"key":"4028_CR8","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1002\/cncr.21825","volume":"106","author":"RA Ghossein","year":"2006","unstructured":"Ghossein RA, Hiltzik DH, Carlson DL, Patel S, Shaha A, Shah JP, Tuttle RM, Singh B (2006) Prognostic factors of recurrence in encapsulated Hurthle cell carcinoma of the thyroid gland: a clinicopathologic study of 50 cases. Cancer 106:1669\u20131676. https:\/\/doi.org\/10.1002\/cncr.21825","journal-title":"Cancer"},{"key":"4028_CR9","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.surg.2022.07.007","volume":"172","author":"BM Humphreys","year":"2022","unstructured":"Humphreys BM, Memeh KO, Funkhouser A, Vaghaiwalla TM (2022) Prognostic factors and survival analysis of Hurthle cell carcinoma: a population-based study. Surgery 172:1379\u20131384. https:\/\/doi.org\/10.1016\/j.surg.2022.07.007","journal-title":"Surgery"},{"key":"4028_CR10","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1089\/thy.2019.0263","volume":"29","author":"KS Wong","year":"2019","unstructured":"Wong KS, Lorch JH, Alexander EK, Marqusee E, Cho NL, Nehs MA, Doherty GM, Barletta JA (2019) Prognostic significance of extent of invasion in poorly differentiated thyroid carcinoma. Thyroid 29:1255\u20131261. https:\/\/doi.org\/10.1089\/thy.2019.0263","journal-title":"Thyroid"},{"key":"4028_CR11","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.humpath.2023.04.005","volume":"136","author":"MA Gubbiotti","year":"2023","unstructured":"Gubbiotti MA, Andrianus S, Sakhi R, Zhang Q, Montone K, Jalaly JB, Baloch Z (2023) Does the presence of capsule influence prognosis in poorly differentiated thyroid carcinoma? Hum Pathol 136:96\u2013104. https:\/\/doi.org\/10.1016\/j.humpath.2023.04.005","journal-title":"Hum Pathol"},{"key":"4028_CR12","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1038\/modpathol.2010.117","volume":"23","author":"S Asioli","year":"2010","unstructured":"Asioli S, Erickson LA, Righi A, Jin L, Volante M, Jenkins S, Papotti M, Bussolati G, Lloyd RV (2010) Poorly differentiated carcinoma of the thyroid: validation of the Turin proposal and analysis of IMP3 expression. Mod Pathol 23:1269\u20131278. https:\/\/doi.org\/10.1038\/modpathol.2010.117","journal-title":"Mod Pathol"},{"key":"4028_CR13","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00428-022-03422-4","volume":"482","author":"B Xu","year":"2023","unstructured":"Xu B, Lubin DJ, Dogan S, Ghossein RA, Viswanathan K (2023) Significance of oncocytic features in poorly differentiated thyroid carcinoma \u2014 a bi-institutional experience. Virchows Arch 482:479\u2013491. https:\/\/doi.org\/10.1007\/s00428-022-03422-4","journal-title":"Virchows Arch"},{"key":"4028_CR14","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1210\/jc.2018-00277","volume":"103","author":"NG Nicolson","year":"2018","unstructured":"Nicolson NG, Murtha TD, Dong W, Paulsson JO, Choi J, Barbieri AL, Brown TC, Kunstman JW, Larsson C, Prasad ML, Korah R, Lifton RP, Juhlin CC, Carling T (2018) Comprehensive genetic analysis of follicular thyroid carcinoma predicts prognosis independent of histology. J Clin Endocrinol Metab 103:2640\u20132650. https:\/\/doi.org\/10.1210\/jc.2018-00277","journal-title":"J Clin Endocrinol Metab"},{"key":"4028_CR15","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41379-021-00907-6","volume":"35","author":"H Park","year":"2022","unstructured":"Park H, Shin HC, Yang H, Heo J, Ki CS, Kim HS, Kim JH, Hahn SY, Chung YJ, Kim SW, Chung JH, Oh YL, Kim TH (2022) Molecular classification of follicular thyroid carcinoma based on TERT promoter mutations. Mod Pathol 35:186\u2013192. https:\/\/doi.org\/10.1038\/s41379-021-00907-6","journal-title":"Mod Pathol"},{"key":"4028_CR16","doi-asserted-by":"publisher","first-page":"652","DOI":"10.3803\/EnM.2022.1477","volume":"37","author":"H Yang","year":"2022","unstructured":"Yang H, Park H, Ryu HJ, Heo J, Kim JS, Oh YL, Choe JH, Kim JH, Kim JS, Jang HW, Kim TH, Kim SW, Chung JH (2022) Frequency of TERT promoter mutations in real-world analysis of 2,092 thyroid carcinoma patients. Endocrinol Metab (Seoul) 37:652\u2013663. https:\/\/doi.org\/10.3803\/EnM.2022.1477","journal-title":"Endocrinol Metab (Seoul)"},{"key":"4028_CR17","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1530\/ERC-22-0151","volume":"29","author":"S Hescot","year":"2022","unstructured":"Hescot S, Al Ghuzlan A, Henry T, Sheikh-Alard H, Lamartina L, Borget I, Hadoux J, Baudin E, Dupuy C, Nikitski AV, Nikiforov YE, Schlumberger M, Nikiforova MN, Leboulleux S (2022) Prognostic of recurrence and survival in poorly differentiated thyroid cancer. Endocr Relat Cancer 29:625\u2013634. https:\/\/doi.org\/10.1530\/ERC-22-0151","journal-title":"Endocr Relat Cancer"},{"key":"4028_CR18","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s12022-023-09769-x","volume":"34","author":"J Metovic","year":"2023","unstructured":"Metovic J, Cabutti F, Osella-Abate S, Orlando G, Tampieri C, Napoli F, Maletta F, Daniele L, Volante M, Papotti M (2023) Clinical and pathological features and gene expression profiles of clinically aggressive papillary thyroid carcinomas. Endocr Pathol 34:298\u2013310. https:\/\/doi.org\/10.1007\/s12022-023-09769-x","journal-title":"Endocr Pathol"},{"key":"4028_CR19","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1089\/thy.2016.0582","volume":"27","author":"B Xu","year":"2017","unstructured":"Xu B, Tuttle RM, Sabra MM, Ganly I, Ghossein R (2017) Primary thyroid carcinoma with low-risk histology and distant metastases: clinicopathologic and molecular characteristics. Thyroid 27:632\u2013640. https:\/\/doi.org\/10.1089\/thy.2016.0582","journal-title":"Thyroid"},{"key":"4028_CR20","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1309\/AJCPQZQN50HKIAHA","volume":"139","author":"M Takeda","year":"2013","unstructured":"Takeda M, Mikami T, Numata Y, Okamoto M, Okayasu I (2013) Papillary thyroid carcinoma with heterotopic ossification is a special subtype with extensive progression. Am J Clin Pathol 139:587\u2013598. https:\/\/doi.org\/10.1309\/AJCPQZQN50HKIAHA","journal-title":"Am J Clin Pathol"},{"key":"4028_CR21","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s00428-013-1484-3","volume":"463","author":"O Koperek","year":"2013","unstructured":"Koperek O, Akin E, Asari R, Niederle B, Neuhold N (2013) Expression of hypoxia-inducible factor 1 alpha in papillary thyroid carcinoma is associated with desmoplastic stromal reaction and lymph node metastasis. Virchows Arch 463:795\u2013802. https:\/\/doi.org\/10.1007\/s00428-013-1484-3","journal-title":"Virchows Arch"},{"key":"4028_CR22","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.humpath.2009.08.011","volume":"41","author":"M Rivera","year":"2010","unstructured":"Rivera M, Ricarte-Filho J, Patel S, Tuttle M, Shaha A, Shah JP, Fagin JA, Ghossein RA (2010) Encapsulated thyroid tumors of follicular cell origin with high grade features (high mitotic rate\/tumor necrosis): a clinicopathologic and molecular study. Hum Pathol 41:172\u2013180. https:\/\/doi.org\/10.1016\/j.humpath.2009.08.011","journal-title":"Hum Pathol"},{"key":"4028_CR23","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1365-2559.2004.01729.x","volume":"44","author":"P Collini","year":"2004","unstructured":"Collini P, Sampietro G, Pilotti S (2004) Extensive vascular invasion is a marker of risk of relapse in encapsulated non-H\u00fcrthle cell follicular carcinoma of the thyroid gland: a clinicopathological study of 18 consecutive cases from a single institution with a 11-year median follow-up. Histopathology 44:35\u201339. https:\/\/doi.org\/10.1111\/j.1365-2559.2004.01729.x","journal-title":"Histopathology"},{"key":"4028_CR24","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/00000478-198604000-00003","volume":"10","author":"W Lang","year":"1986","unstructured":"Lang W, Choritz H, Hundeshagen H (1986) Risk factors in follicular thyroid carcinomas. A retrospective follow-up study covering a 14-year period with emphasis on morphological findings. Am J Surg Pathol 10:246\u2013255","journal-title":"Am J Surg Pathol"},{"key":"4028_CR25","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1097\/PAS.0000000000001208","volume":"43","author":"V Cracolici","year":"2019","unstructured":"Cracolici V, Kadri S, Ritterhouse LL, Segal JP, Wanjari P, Cipriani NA (2019) Clinicopathologic and molecular features of metastatic follicular thyroid carcinoma in patients presenting with a thyroid nodule versus a distant metastasis. Am J Surg Pathol 43:514\u2013522. https:\/\/doi.org\/10.1097\/PAS.0000000000001208","journal-title":"Am J Surg Pathol"},{"key":"4028_CR26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12022-022-09707-3","volume":"33","author":"ZW Baloch","year":"2022","unstructured":"Baloch ZW, Asa SL, Barletta JA, Ghossein RA, Juhlin CC, Jung CK, LiVolsi VA, Papotti MG, Sobrinho-Sim\u00f5es M, Tallini G, Mete O (2022) Overview of the 2022 WHO classification of thyroid neoplasms. Endocr Pathol 33:27\u201363. https:\/\/doi.org\/10.1007\/s12022-022-09707-3","journal-title":"Endocr Pathol"},{"key":"4028_CR27","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1097\/PAS.0b013e3180309e6a","volume":"31","author":"M Volante","year":"2007","unstructured":"Volante M, Collini P, Nikiforov YE, Sakamoto A, Kakudo K, Katoh R, Lloyd RV, LiVolsi VA, Papotti M, Sobrinho-Simoes M, Bussolati G, Rosai J (2007) Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol 31:1256\u20131264. https:\/\/doi.org\/10.1097\/PAS.0b013e3180309e6a","journal-title":"Am J Surg Pathol"},{"key":"4028_CR28","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/PAP.0000000000000162","volume":"24","author":"S Hendry","year":"2017","unstructured":"Hendry S, Salgado R, Gevaert T et al (2017) Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the international immunooncology biomarkers working group: part 1: assessing the host immune response, TILs in invasive breast carcinoma and ductal carcinoma in situ, metastatic tumor deposits and areas for further research. Adv Anat Pathol 24:235\u2013251. https:\/\/doi.org\/10.1097\/PAP.0000000000000162","journal-title":"Adv Anat Pathol"},{"key":"4028_CR29","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1507\/endocrj.EJ22-0010","volume":"69","author":"HQ Wang","year":"2022","unstructured":"Wang HQ, Li Y, Song X, Ma YQ, Li JL, Li YX, Wang GF, Liu P, Liu PL, Cao S, Shi HY (2022) Significance of interstitial fibrosis and p16 in papillary thyroid carcinoma. Endocr J 69:1253\u20131259. https:\/\/doi.org\/10.1507\/endocrj.EJ22-0010","journal-title":"Endocr J"},{"key":"4028_CR30","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1007\/s40618-020-01456-6","volume":"44","author":"MM Moura","year":"2021","unstructured":"Moura MM, Cabrera RA, Esteves S, Cavaco BM, Soares P, Leite V (2021) Correlation of molecular data with histopathological and clinical features in a series of 66 patients with medullary thyroid carcinoma. J Endocrinol Invest 44:1837\u20131846. https:\/\/doi.org\/10.1007\/s40618-020-01456-6","journal-title":"J Endocrinol Invest"},{"key":"4028_CR31","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s00268-005-0391-4","volume":"30","author":"C Scheuba","year":"2006","unstructured":"Scheuba C, Kaserer K, Kaczirek K, Asari R, Niederle B (2006) Desmoplastic stromal reaction in medullary thyroid cancer - an intraoperative \u201cmarker\u201d for lymph node metastases. World J Surg 30:853\u2013859. https:\/\/doi.org\/10.1007\/s00268-005-0391-4","journal-title":"World J Surg"},{"key":"4028_CR32","doi-asserted-by":"publisher","first-page":"188356","DOI":"10.1016\/j.bbcan.2020.188356","volume":"1873","author":"B Piersma","year":"2020","unstructured":"Piersma B, Hayward MK, Weaver VM (2020) Fibrosis and cancer: a strained relationship. Biochim Biophys Acta Rev Cancer 1873:188356. https:\/\/doi.org\/10.1016\/j.bbcan.2020.188356","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"4028_CR33","doi-asserted-by":"publisher","first-page":"188443","DOI":"10.1016\/j.bbcan.2020.188443","volume":"1874","author":"Q Meng","year":"2020","unstructured":"Meng Q, Luo X, Chen J, Wang D, Chen E, Zhang W, Zhang G, Zhou W, Xu J, Song Z (2020) Unmasking carcinoma-associated fibroblasts: key transformation player within the tumor microenvironment. Biochim Biophys Acta Rev Cancer 1874:188443. https:\/\/doi.org\/10.1016\/j.bbcan.2020.188443","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"4028_CR34","doi-asserted-by":"publisher","first-page":"12578","DOI":"10.3390\/ijms232012578","volume":"23","author":"E Shin","year":"2022","unstructured":"Shin E, Koo JS (2022) Cell component and function of tumor microenvironment in thyroid cancer. Int J Mol Sci 23:12578. https:\/\/doi.org\/10.3390\/ijms232012578","journal-title":"Int J Mol Sci"},{"key":"4028_CR35","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ejca.2017.01.013","volume":"75","author":"M Tahara","year":"2017","unstructured":"Tahara M, Schlumberger M, Elisei R, Habra MA, Kiyota N, Paschke R, Dutcus CE, Hihara T, McGrath S, Matijevic M, Kadowaki T, Funahashi Y, Sherman SI (2017) Exploratory analysis of biomarkers associated with clinical outcomes from the study of lenvatinib in differentiated cancer of the thyroid. Eur J Cancer 75:213\u2013221. https:\/\/doi.org\/10.1016\/j.ejca.2017.01.013","journal-title":"Eur J Cancer"},{"key":"4028_CR36","doi-asserted-by":"publisher","first-page":"3557","DOI":"10.1210\/jc.2018-01167","volume":"104","author":"R Giannini","year":"2019","unstructured":"Giannini R, Moretti S, Ugolini C, Macerola E, Menicali E, Nucci N, Morelli S, Colella R, Mandarano M, Sidoni A, Panfili M, Basolo F, Puxeddu E (2019) Immune profiling of thyroid carcinomas suggests the existence of two major phenotypes: an ATC-like and a PDTC-like. J Clin Endocrinol Metab 104:3557\u20133575. https:\/\/doi.org\/10.1210\/jc.2018-01167","journal-title":"J Clin Endocrinol Metab"},{"key":"4028_CR37","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3390\/cancers12010112","volume":"12","author":"E Minna","year":"2020","unstructured":"Minna E, Brich S, Todoerti K, Pilotti S, Collini P, Bonaldi E, Romeo P, Cecco L, Dugo M, Perrone F, Busico A, Vingiani A, Bersani I, Anichini A, Mortarini R, Neri A, Pruneri G, Greco A, Borrello MG (2020) Cancer associated fibroblasts and senescent thyroid cells in the invasive front of thyroid carcinoma. Cancers (Basel) 12:112. https:\/\/doi.org\/10.3390\/cancers12010112","journal-title":"Cancers (Basel)"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-025-04028-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-025-04028-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-025-04028-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T05:30:55Z","timestamp":1759296655000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-025-04028-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,23]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["4028"],"URL":"https:\/\/doi.org\/10.1007\/s00428-025-04028-2","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,23]]},"assertion":[{"value":"2 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}